"I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa
- PMID: 28202021
- PMCID: PMC5311841
- DOI: 10.1186/s12910-017-0175-z
"I passed the test!" Evidence of diagnostic misconception in the recruitment of population controls for an H3Africa genomic study in Cape Town, South Africa
Abstract
Background: Advances in genetic and genomic research have introduced challenges in obtaining informed consent for research in low and middle-income settings. However, there are only few studies that have explored challenges in obtaining informed consent in genetic and genomic research in Africa and none in South Africa. To start filling this gap, we conducted an empirical study to investigate the efficacy of informed consent procedures for an H3Africa genomic study on Rheumatic Heart Disease (RHDGen) at the University of Cape Town in South Africa. The main aim of the study was to understand ethical challenges in obtaining informed consent in the RHDGen study.
Methods: We used a qualitative study methodology involving in-depth interviews and participant observations. Our study participants were RHDGen cases (patients), healthy controls and research staff involved in the recruitment of RHDGen cases and controls. In total, we conducted 32 in-depth interviews with RHDGen cases and controls, 2 in-depth interviews with research staff and 57 direct observations of the consent procedures of RHDGen cases and controls. The interviews were conducted in English, audio-recorded and transcribed verbatim. Data were analyzed using thematic content analysis. The study was conducted in 3 sites within Cape Town, South Africa.
Results: Most healthy controls joined the RHDGen study in order to be screened for rheumatic heart disease (diagnostic misconception). A majority of RHDGen cases decided to join the RHDGen study because of therapeutic misconception.
Conclusion: The ethical challenges that impacted on obtaining informed consent in the RHDGen study were complex. In this study, the main challenges were diagnostic misconception among RHDGen controls and therapeutic misconception among RHDGen cases.
Keywords: Diagnostic misconception; Genetic studies; Genomic studies; In-depth interviews; Informed consent; Observations; Qualitative study; Therapeutic misconception.
Similar articles
-
Use of broad consent and related procedures in genomics research: Perspectives from research participants in the Genetics of Rheumatic Heart Disease (RHDGen) study in a University Teaching Hospital in Zambia.Glob Bioeth. 2019 Mar 24;31(1):184-199. doi: 10.1080/11287462.2019.1592868. Glob Bioeth. 2019. PMID: 33343192 Free PMC article.
-
Phase 3 Oncology Clinical Trials in South Africa: Experimentation or Therapeutic Misconception?J Empir Res Hum Res Ethics. 2016 Feb;11(1):47-56. doi: 10.1177/1556264616637736. J Empir Res Hum Res Ethics. 2016. PMID: 27106890 Clinical Trial.
-
Understandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.BMC Med Ethics. 2015 Jun 16;16:42. doi: 10.1186/s12910-015-0035-7. BMC Med Ethics. 2015. PMID: 26077875 Free PMC article.
-
Therapeutic misconception and clinical trials in sub-Saharan Africa: a review.East Afr Med J. 2009 Jun;86(6):291-9. doi: 10.4314/eamj.v86i6.54142. East Afr Med J. 2009. PMID: 20358792 Review.
-
[Ethics of medical scientific research: informed consent and the therapeutic misconception].Ned Tijdschr Geneeskd. 2008 Mar 22;152(12):679-83. Ned Tijdschr Geneeskd. 2008. PMID: 18438063 Review. Dutch.
Cited by
-
The critical needs and challenges for genetic architecture studies in Africa.Curr Opin Genet Dev. 2018 Dec;53:113-120. doi: 10.1016/j.gde.2018.08.005. Epub 2018 Sep 18. Curr Opin Genet Dev. 2018. PMID: 30240950 Free PMC article. Review.
-
Translational Science, DNA Commercialization, and Informed Consent: The Need for Specific Terminology, Insights from a Review of H3Africa Projects.Public Health Genomics. 2022 Jan 25;25(3-4):1-8. doi: 10.1159/000521371. Online ahead of print. Public Health Genomics. 2022. PMID: 35078200 Free PMC article.
-
Rules of engagement: perspectives on stakeholder engagement for genomic biobanking research in South Africa.BMC Med Ethics. 2018 Feb 27;19(1):13. doi: 10.1186/s12910-018-0252-y. BMC Med Ethics. 2018. PMID: 29482536 Free PMC article.
-
Use of broad consent and related procedures in genomics research: Perspectives from research participants in the Genetics of Rheumatic Heart Disease (RHDGen) study in a University Teaching Hospital in Zambia.Glob Bioeth. 2019 Mar 24;31(1):184-199. doi: 10.1080/11287462.2019.1592868. Glob Bioeth. 2019. PMID: 33343192 Free PMC article.
-
Informed consent in genomic research and biobanking: taking feedback of findings seriously.Glob Bioeth. 2020 Feb 23;31(1):200-215. doi: 10.1080/11287462.2020.1717896. Glob Bioeth. 2020. PMID: 33343193 Free PMC article.
References
-
- Pace C. Grady C. Emanuel EJ. What we don’t know about informed consent. SciDev.net. 2003.www.scidev.net/global/health/.../what-we-dont-know-about-informed-consen.... Accessed 14 Feb 2017.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous